AI has taken the world by storm in recent years, including healthcare. Yet its full potential remains untapped. This year’s Future Health Index report explores this potential, how AI is already helping clinicians and patients today, and what is needed to build trust in healthcare AI, enabling better adoption of the technology and better patient outcomes.
The largest global survey of its kind, analyzing the perspectives of healthcare professionals and patients on the use of AI and digital technologies in healthcare.
Most healthcare professionals are optimistic about AI’s potential to improve healthcare. Patients are less convinced, highlighting a notable trust divide.
They also see potential for AI to have significant
Healthcare professionals recognize that AI
technology can free up their time and
improve access to care.
positive impact on their department:
They also see potential for AI to have significant positive impact on their department:
Healthcare professionals recognize that AI technology can free up their time and improve access to care.
Healthcare professionals stated that AI can positively impact their department by shortening procedure times and increasing personalized care.
Jeff DiLullo
Chief Region Leader
Philips North America
The Future Health Index is commissioned by Philips In its 10th edition, the Future Health Index 2025 investigates how innovative technologies, particularly artificial intelligence (AI), can empower healthcare professionals to deliver better care for more people. Two quantitative surveys were carried out among over 1,900 healthcare professionals and over 16,000 patients in 16 countries (Australia, Brazil, Canada, China, France, Germany, India, Indonesia, Japan, Netherlands, Saudi Arabia, Spain, South Africa, South Korea, the United Kingdom and the United States). The surveys were conducted from December 2024 to April 2025.
You are now exiting the Philips United States (US) site and entering the Philips global site. This content is intended for a global audience. It may not apply to the US and should not be interpreted as meeting US standards, executive orders or regulations.
Continue